Business Wire

Animal Planet, KONG, ORIJEN, Pedigree and Whiskas Among 92 Winners of the 2017 Animalis Edition of the World Branding Awards

Del

The Animalis edition of the prestigious World Branding Awards saw 92 brands from 35 countries named “Brand of the Year” in a glittering ceremony held at the Hofburg Palace in Vienna today. The Animalis edition of the Awards focused on pet and animal brands.

Animal Planet, FURminator, Hill's Prescription Diet, KONG, ORIJEN, Pedigree, Petplan, PURINA Pro Plan, Red Dingo, Tetra and Whiskas were announced as global winners. Regional winners were Equi-Trek (United Kingdom), Evidensia (Sweden), Fressnapf | Maxi Zoo (Germany) and Horze (Finland).

National tier winners included V.I.P. Petfoods (Australia), Aeon Pet (Japan), Amiguard (Switzerland), Avanti (India), Benelux (Belgium), CP Prima (Indonesia), Cunipic Alpha Pro (Spain), Dolina Noteci (Poland), Dubai Aquarium & Underwater Zoo (United Arab Emirates), Earth Rated (Canada), Equsana (Denmark), Irish Rover (Ireland), JerHigh (Thailand), JUWEL Aquarium (Germany), Lord Lou (Netherlands), Manfred of Sweden (Sweden), MONGE (Italy), MUSH (Finland), NatureBridge (China), Oasy (San Marino/Italy), Pet Lovers Centre (Singapore), PetCenter (Czech Republic), Pets At Home (United Kingdom), Pi-Pi-Bent (Russia), Powercat (Malaysia), Puppia (South Korea), Q-Pets (Hong Kong), Rogz (South Africa), Royal Canin (France), Top Breed (Philippines), Vetmeduni Vienna (Austria), YU (Taiwan) and Ziwi Peak (New Zealand), among others.

Four NGOs – the Borneo Orangutan Survival Foundation (Indonesia), The David Sheldrick Wildlife Trust (Kenya), The Jane Goodall Institute (United States) and Wildlife Friends Foundation (Thailand) – were also recognised for their work.

The Awards celebrates the achievements of some of the greatest brands around the globe. Uniquely, winners are judged through three streams: brand valuation, consumer market research, and public online voting. Each brand was named “Brand of the Year” in their respective categories.

The Awards is organised by the World Branding Forum, a global non-profit organisation dedicated to advancing branding standards for the good of the branding community as well as consumers. It organises and sponsors a range of educational programmes, and has joint collaborations with leading universities and museums. The Forum also publishes branding news on its website that reaches a global audience of over 4 million visitors.

“The Animalis edition of the Awards pays tribute to the achievements of pet and animals brands from around the world. Consumer votes count towards 70 per cent of the final score, so winning brands have to have built a strong relationship with their customers in order to win,” said Richard Rowles, Chairman of the World Branding Forum.

“Over 60,000 pet and animal lovers from around the world voted for more than 800 brands from 35 countries. Winning brands have had to work hard to stand out from the tough competition,” said Peter Pek, Chief Executive of the Forum.

The event was hosted by Stuart Freeman from Radio FM4 in Austria. For more information and the full list of winners, visit awards.brandingforum.org.

###

About the World Branding Forum
The World Branding Forum (WBF) is a registered global non-profit organisation. Its aims and activities are to provide raise the standards of branding for the good of the industry as well as consumers. The WBF produces, manages and supports a wide range of programmes covering research, development, education, recognition, networking and outreach. For more information, visit brandingforum.org.

About the World Branding Awards
The World Branding Awards is the premier awards of the World Branding Forum, a registered non-profit organisation. The awards recognises the achievements of some of the world’s best brands. There are three major tiers of awards – the Global Award is awarded to international brands, Regional Award for brands that cover a geographic region, while the National Award is awarded to brands that are household names in their country of origin. For more information, visit https://awards.brandingforum.org.

Contact information

World Branding Forum
Peter Michaels
+44 (0) 20 3743 9880

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

LivaNova Enters into Binding Letter of Intent to Sell its Cardiac Rhythm Management Business Franchise to MicroPort Scientific Corporation for $190 Million20.11.2017 08:43Pressemelding

LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, manufactures and markets products for the diagnosis, treatment and management of heart rhythm disorders and heart failures. CRM products include high-voltage defibrillators, cardiac resynchronization therapy devices and low-voltage pacemakers. The CRM Business Franchise generated approximately $249 million in net sales in fiscal year 2016 and has approximately 900 employees with operations chiefly in Clamart, France; Saluggia, Italy; and Santo Domingo, Dominican Republic. MicroPort is a leading medical device company, focused on innova

Chugai's Bispecific Antibody Emicizumab Meets Primary Endpoint in Phase lll Study20.11.2017 08:29Pressemelding

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced today that the primary endpoint has been met for the global phase lll HAVEN 3 (NCT02847637) study evaluating emicizumab (ACE910) subcutaneous injection, once a week and once every two weeks, in patients with hemophilia A (12 years of age or older) without inhibitors to factor Vlll. A statistically significant reduction in the number of bleeds was confirmed in patients treated with emicizumab prophylaxis compared to those receiving no prophylactic treatment. The study also met a secondary endpoint that once-weekly emicizumab prophylaxis was superior to factor VIII prophylaxis, as demonstrated by a statistically significant and clinically meaningful reduction in treated bleeds in an intra-patient comparison of patients receiving emicizumab prophylaxis compared to their prior factor VIII prophylaxis. The most common adverse events with em

Fiorano Launches PSD2 Solution for Banks for Seamless Regulatory Compliance20.11.2017 08:00Pressemelding

Fiorano Software, a proven global leader in Integration Middleware and API Management, today announced the launch of Fiorano PSD2, a platform solution enabling banks to comply with the European Union’s Revised Payment Service Directive (PSD2) regulations. Fiorano’s end-to-end PSD2 solution is built on the industry's leading banking Integration and API Management infrastructure serving as an onramp for future eDigital Banking initiatives. Banks across Europe need to be PSD2 compliant by January 2018. They are also facing severe competition from FinTechs to improve online payments, customer engagement experiences and making cross-border payments safer. “By building on PSD2 as a solution on top of a tightly integrated API Management and ESB platform, Fiorano masks complex technical details, dramatically simplifies the time and effort for compliance,” said Mr. Atul Saini, CEO of Fio

Synteract Thought Leaders to Speak & Exhibit at Partnerships in Clinical Trials Europe in Amsterdam20.11.2017 08:00Pressemelding

(Booth #17) – Thought leaders from Synteract, a full-service, international contract research organization (CRO), will exhibit and present at Partnerships in Clinical Trials Europe (PCT), November 28-29, Amsterdam, Netherlands. With awareness of the shifting CRO landscape and the complexity this represents to biopharma companies as they make critical outsourcing decisions, Synteract invites attendees to “Pause to rethink what matters most from your CRO.” Vice President, Global Medical and Regulatory Affairs at Synteract, Dr. Martine Dehlinger-Kremer, will speak on “The EU Clinical Trials Regulation: Are you prepared for its implementation?” at the event on Tuesday, November 28 at noon. She will address how evolving industry needs are driving momentum towards implementation of a new regulation governing clinical trials, the expected impact on sponsors and necessary steps toward p

Record Attendance at Japan Content Showcase 2017!20.11.2017 03:00Pressemelding

Japan Content Showcase 2017 was held October 23-26 at Ikebukuro Sunshine City and the Shibuya Excel Hotel Tokyu. A record 19,549 people participated in sales meetings, excluding the TIMM Showcase Live. Other new records this year were 371 exhibiting groups from 27 countries and regions and 1,549 buyers from 48 countries and regions. There was a significant increase in overseas buyers this year, the 1022 foreign registrations representing an increase of more than 10% over last year. The number of non-Japanese Asian buyers increased by 6%, North Americans by 13%, South Americans by 44%, and Europeans by 49%. The number of Middle Eastern buyers doubled, and there were more than five times the number of Russian buyers as last year. French buyers were up 70%, Italians 60%, British 75%, and Germans 50%. Business matching was a new service offered by the organizers this year. Meeti

Shell, bio-bean and Coffee-Drinkers Collaborate to Help Power London’s Buses20.11.2017 00:01Pressemelding

Shell and bio-bean announce that together they are helping to power some of London’s buses using a biofuel made partly from waste coffee grounds. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171119005060/en/ Shell and bio-bean announce that together they are helping to power some of London's buses using a biofuel made partly from waste coffee grounds (Photo: Business Wire) The B20 biofuel contains a 20% bio-component which contains part coffee oil. The biofuel is being added to the London bus fuel supply chain and will help to power some of the buses; without need for modification. Biofuel provides a cleaner, more sustainable energy solution for buses across London’s network by decreasing emissions1. “Our Coffee Logs have already become the fuel of choice for households looking for a

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom